VYXEOS (vix-e-ose) is an intravenous (IV) chemotherapy used for the treatment of adults with certain types of newly-diagnosed acute myeloid leukemia: t-AML or AML-MRC.
Therapy-related AML (t-AML)
AML in people who have previously received chemotherapy or radiation therapy
AML with myelodysplasia-related changes (AML-MRC)
AML in people who have previously had certain types of blood disorders